Stocks Hitting 52-Week Lows

Oncolytics Biotech ONCY shares dropped 17.73% to create a new 52-week low of $2.32. Oncolytics Biotech provided an update on its Phase III trial of REOLYSIN for the treatment of head and neck cancers. Value Line VALU shares fell 2.16% to create a new 52-week low of $9.95. Value Line shares have dropped 15.32% over the past 52 weeks, while the S&P 500 index has gained 22.23% in the same period. Lawson Products LAWS shares dipped 10.34% to create a new 52-week low of $6.50. Lawson Products' PEG ratio is -2.41. China Ceramics Co Ltd CCCL shares declined 18.88% to create a new 52-week low of $2.02. China Ceramics expects Q4 revenue to drop by around 20% to 40% versus the fourth quarter of the previous year.